Trial Profile
A Multinational, Multicenter, Retrospective, Observational Drug Utilisation Study of Seroquel Extended Release (XR) Prescribed by Psychiatrists as Treatment for Major Depressive Disorder (MDD) in Selected Countries in the European Union (EU)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2017
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms EUDUS
- Sponsors AstraZeneca
- 24 Oct 2017 Results published in the International Clinical Psychopharmacology
- 20 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 May 2012 New trial record